# Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease

Study · id `cardio:ct-nct02417883` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02417883](<https://clinicaltrials.gov/study/NCT02417883>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02417883

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02417883. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-04 (registry gives no type); primary completion 2016-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02417883, source copy `cardio:ctgov-nct02417883-2015-04-16`, retrieved 2026-10-26)
- Start date: 2015-04 (registry gives no type) (ClinicalTrials.gov record NCT02417883, source copy `cardio:ctgov-nct02417883-2015-04-16`, retrieved 2026-10-26)
- Primary completion: 2016-04 (anticipated) (ClinicalTrials.gov record NCT02417883, source copy `cardio:ctgov-nct02417883-2015-04-16`, retrieved 2026-10-26)
- Completion: 2017-04 (anticipated) (ClinicalTrials.gov record NCT02417883, source copy `cardio:ctgov-nct02417883-2015-04-16`, retrieved 2026-10-26)
- Countries: Mexico (ClinicalTrials.gov record NCT02417883, source copy `cardio:ctgov-nct02417883-2015-04-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02417883-2015-04-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease
- Acronym: FST-IFTA
- Condition: Chronic Kidney Disease
- Intervention (Drug): Furosemide
- Lead sponsor: Instituto Nacional de Cardiologia Ignacio Chavez
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Instituto Nacional de Cardiologia Ignacio Chavez (`cardio:org-instituto-nacional-de-cardiologia-ignacio-chavez`)

## Provenance

Content hash: ceb24bcbd22f69d72b640d669eb7c2cc6048430b86893ea1992ac274c87fe7a2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
